newsfilter
← Latest News
GlobeNewswire·

PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights

Updated clinical results from Phase 2 pivotal portion of the PYNNACLE study evaluating rezatapopt featured in late-breaking oral presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and